ARTG Entry
EBGLYSS
ARTG entry for EBGLYSS (lebrikizumab), ARTG 406290 — Product Information, dosage form, registration history. Compiled by arcimedes.
- Sponsor: Eli Lilly
- Active ingredient: lebrikizumab
- Therapeutic area: Dermatology
ARTG Entry
ARTG entry for EBGLYSS (lebrikizumab), ARTG 406290 — Product Information, dosage form, registration history. Compiled by arcimedes.